biosimilars News

Biocon set to seek USFDA approval for biosimilars

Biosimilars are copies of biological drugs with same safety and efficacy as original products. The addressable market for Biocon in these countries is more than $30 billion.

'India's biotech sector to grow 20%'

Biofuels would also offer a huge growth opportunity in biotech,Kiran Mazumdar-Shaw said.


Biocon Q1 net up 33% at Rs 77 cr

Biotech major Biocon today reported a consolidated net profit...